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Objectives. Describe older patients’ perceptions about depression and characteristics associated with acceptance of treatments.
Design. Cross-sectional study. Setting. Three primary care clinics in Iowa. Participants. Consecutive sample of 529 primary care
patients. Measurements. Depression screening tool (a 9-item patient health questionnaire [PHQ-9]) and questionnaire including
sociodemographic data, patient attitudes about depression, and acceptability of different treatments. Results. Mean age was 71.9
years (range 60–93 years), 314 (59%) female. Among the 529 participants, 93 (17.5%) had history of depression and 60 (11.3%) had
PHQ-9 scores of 10 or greater. Participants believed depression is a disease for which they would use medication and counseling.
Accepting medications from primary physicians was strongly associated with a past history of depression (𝑃 < 0.01) and with
agreeing that depression needs treatment (𝑃 < 0.01). Counseling was not acceptable for those believing that they can control
depression on their own (𝑃 < 0.01). Older patients (𝑃 < 0.001) and those with higher education levels (𝑃 < 0.01) were less likely
to accept herbs or supplements as treatment options. Willingness to discuss treatments with family was associated with not using
alcohol as a treatment and acceptance of all other treatment options (𝑃 < 0.001). Conclusions. Attitude that depression is a disease
and the willingness to discuss depression with family may enhance treatment acceptance.

1. Introduction
Clinically relevant depressive symptoms are present in about
20% of community-dwelling persons aged 75 years and older
[1]. Late-life depression affects at least 5–10% of older primary
care patients [2]. Depression often coexists with chronic
medical conditions, such as dementia, Parkinson’s disease,
and vascular disease, and influences the prognosis of other
diseases [3–5]. Depression in primary care patients aged 55
years and older has a poor prognosis [6]. Persistent depressive
symptoms are associated with lower perceived health status,
patient barriers to self-management [7], and higher mortality
[8]. Remission of symptoms of depression is associated with
reduction in mortality [9].
About 40–50% of older adults with nonpsychotic major
depressive disorder (MDD) respond satisfactorily to the first
prescribed antidepressant medication [10, 11]. With vigorous

and persistent treatment, up to 90 percent of older depressed
patients will respond to drug therapy [12]. Within two years
60% of community-dwelling older adults with MDD became
depressed again unless they were maintained on antidepressant medication [13]. Poor adherence to taking medications
may account for a substantial proportion of treatment failures
[14, 15]. Patients’ compliance and continuous treatment are
important.
Adherence to depression treatment in late-life depression
is associated with potentially modifiable factors, including
patients’ attitudes, beliefs, and social norms [16]. Attitudes
include perceived effectiveness of treatment, preferences for
types of treatment, and patient resistance to viewing depression as a medical disease [17, 18]. Social norms including
stigma of the depression diagnosis and the impact of caregivers’ agreement with treatment recommendations influence
treatment compliance [16, 19, 20].
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The purpose of this study is to describe the perceptions
of older ambulatory care patients about depression and characteristics associated with acceptance of various depression
treatments.

2. Materials and Methods
2.1. Subjects. Between November 2008 and March 2009 all
persons 60 years of age or older visiting one of three primary
care clinics were given a packet of research materials and
asked by the clinic receptionists to consider participating
in the study. Two of the clinics, the Family Medicine and
General Internal Medicine clinics, are located at the University of Iowa Hospitals and Clinics in Iowa City, IA. The
third clinic is a free-standing primary care office in North
Liberty, IA. After reading a brief cover letter explaining the
research protocol, patients elected to open the packet and
complete the questionnaire or to return the packet without
completing the questionnaire. Seventy percent of patients
who were offered participation completed the study. Age and
gender distributions were similar between participants and
nonparticipants. Patients who completed the questionnaire
were asked to consider sharing the results of the PHQ-9
portion with their physicians during their visit.
2.2. Questionnaire. The survey instrument was four pages
containing 38 large-print questions. Included were questions about demographics, religious beliefs, chronic medical problems, and a general rating of health status. Questions regarding depression included history of physiciandiagnosed depression and previous treatments used. Using
a five-point Likert scale, participants were asked about their
beliefs regarding depression and the treatments that would be
acceptable to them if they were depressed. The questionnaire
was adapted from instruments in the literature, including
the ADepT questionnaire [21]. The final portion of the
questionnaire was the PHQ-9 diagnostic survey [22, 23].
2.3. Consent. Capacity to consent was inferred by the participants’ ability to travel to the clinic site and complete the necessary procedures to register into the clinic. If potential participants were unable to check into the clinic by themselves,
their accompanying adult was given the research packet for
consideration of having the elder patient participate. The
project was approved by the University of Iowa Institutional
Review Board.
2.4. Analysis. Descriptive statistics were obtained for all
demographic and questionnaire variables. Mean differences
in ratings of questionnaire items of ordinal variables were
examined by 𝑡-test and one-way ANOVA. The chi-square
test was used to examine the similarities in frequencies of
categorical values. Subjects were grouped into depressed or
non depressed categories by virtue of their answer to the
question, “Do you have a history of depression?” PHQ-9
scores were used as a continuous variable to assess current
depressive symptoms.
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Stepwise linear regression method was used to identify
predictors of outcome variables. Each of the seven outcome
variables was regressed on variables of demographics, attitudes about depression and treatments, and circumstances
influencing treatment. Variables associated with an outcome
variable with a 𝑃 value of 0.20 or less were included as
potential explanatory variables. In addition, the selected and
excluded variables were checked for scientific plausibility
based on past association with depressive symptoms. Using
collinearity diagnostics for each final model, no strong
collinearity was detected. The analysis was performed using
SAS (SAS 9.2, SAS Institute, Inc., Cary, NC).

3. Results
The mean age of the study sample was 71.9 years; 59.4% were
female, 57.1% married, and 65.7% retired. Less than 1% had no
insurance, and 50% had a college or higher educational level.
Self-reported health was listed as fair or poor by 19.2%, and
15% of the sample had four or more chronic diseases (Table 1).
Ninety-three (17.5%) participants had a past history of
depression and were older (𝑃 = 0.05), had poorer selfreported health (𝑃 = 0.01), were more likely to be female (13%
versus 5%, 𝑃 = 0.005), and were likely to have had a diagnosis
of heart disease or stroke (25% versus 16%, 𝑃 = 0.04). Sixty
(11.3%) had PHQ-9 scores of 10 or greater, and 134 (25%) had
PHQ-9 scores of 5 or greater.
Participants believed depression is a disease, not a part
of normal aging, and requires treatment. They perceived
an inability to control depression by themselves and that
treatment for depression is not embarrassing (Table 2). There
was general agreement by participants that they could afford
treatment, and they would not decline treatment because
of age, life circumstances, or other more important medical
problems. There was agreement that they would discuss
treatment with their family and a sense that families would
want them to be treated if they were depressed (Table 2).
Participants also agreed that, if they were depressed, they
would use medication and counseling and follow their doctor’s recommendations. They were less likely to use prayer
or herbal supplements and would not consider alcohol as a
treatment option (Table 3).
Depressive symptoms measured by the PHQ-9 scores
were associated with the degree of agreement with statements
regarding depression and treatments (Table 4). Compared
to nondepressed participants, participants currently with
depressive symptoms were less likely to disagree with beliefs
that “depression means you are weak,” “depression is a normal
part of aging,” “treatment for depression is embarrassing,”
“I could not afford treatment for depression,” and “I could
not travel to receive treatment for depression.” Subjects with
depressive symptoms were also less likely to agree to discuss
treatment with family members.
In regression analyses, accepting medications from the
primary physician was strongly associated with a past history
of depression (𝑃 < 0.01) and with agreeing that depression
needs treatment (𝑃 < 0.01) and that depression is caused by
life events (𝑃 < 0.05). Agreement to receive medication from
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Table 1: Characteristics of the study sample 𝑁 = 529, ( ) = %.
Age
Mean
Range
Gender
Males
Females
Marital status
Married
Widowed
Divorced
Single, never married
Other
Employment status
Retired
Employed
Disabled
Homemaker
Unemployed
Education
<12 yrs
12–15 yrs
≥16 yrs
Medical visits past 3 months
None
1–3
4–6
>6
Medical insurance∗
Medicare
Private
Medicaid
Other
None
Religious beliefs
Strong
Average
Weak
None
Religious services attended
>1/week
1/week
1-2/month
1-2/year
Almost never
Number of chronic diseases+
0
1
2
3
≥4

71.9 yrs
60–93 yrs
(40.6)
(59.4)

Table 1: Continued.
General health rating
Excellent
Very good
Good
Fair
Poor

(8.1)
(31.0)
(41.7)
(16.9)
(2.3)

∗

More than one answer may apply.
Disease prevalence: arthritis (45.0), hypertension (42.4), diabetes (19.1),
thyroid disease (17.6), nonskin cancer (13.5), asthma/bronchitis (11.8), heart
attack (8.4), heart failure (6.3), angina (6.3), and stroke (5.9).
+

(57.1)
(20.2)
(15.7)
(5.7)
(1.3)
(65.7)
(21.9)
(6.1)
(4.8)
(1.5)
(5.7)
(44.4)
(49.9)
(21.9)
(58.7)
(13.7)
(5.7)
(79.1)
(58.9)
(12.6)
(17.2)
(0.6)
(36.5)
(41.7)
(10.6)
(11.2)
(8.8)
(30.6)
(13.3)
(13.6)
(33.7)
(17.4)
(27.3)
(26.7)
(13.5)
(15.1)

a psychiatrist was positively related to accepting the statement
that depression needs treatment (𝑃 < 0.01) and negatively
associated with the feeling that medications would not help
(𝑃 < 0.001). Counseling was not acceptable treatment for
those believing they can control depression on their own
(𝑃 < 0.01) or those thinking treatment was embarrassing
(𝑃 < 0.001). Older patients (𝑃 < 0.001) and those with higher
education levels (𝑃 < 0.01) are less likely to accept herbs
or supplements as treatment options. Persons with greater
religious belief accept prayer as a treatment (𝑃 < 0.001) and
would not use alcohol (𝑃 < 0.001). Willingness to discuss
treatments with family was highly associated with not using
alcohol and acceptance of all other treatment options (𝑃 <
0.001) (Table 5).

4. Discussion
Our sample exhibited a general attitude that depression is a
disease physicians should ask about and is not necessarily
a part of normal aging. Depression is thought to require
treatment to improve, and being treated for depression is not
embarrassing. These findings are similar to a nationally representative cross-sectional survey of American households
showing positive mental health treatment beliefs in over
70% of persons 55 years of age or older [24]. Participants
perceive that treatment is affordable, accessible and should
not be avoided because of age, life circumstances, or other
medical problems. These older adults would accept medication treatments for depression from their primary doctors
or psychiatrists and consider counseling an acceptable intervention. This is consistent with a systematic review showing
that between 49% and 84% of depressed or anxious patients
perceive a need for counseling or medications [25]. As
previously reported, most depressed older adults in primary
care settings wish to receive some forms of treatment for their
depression [26].
The types of treatments used by participants diagnosed
with depression were not associated with the attitude variables. This may be due to a lack of power in the sample
of 93 with past diagnoses of depression or may indicate, in
persons accepting the diagnosis of depression, that attitudes
do not influence treatment choices. Persons with greater
depressive symptoms tended to agree or disagree in the
same direction regarding the attitudes about depression as
older persons without depressive symptoms. The degree of
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Table 2: Attitudes about depression and treatment.
𝑁

Mean∗

Std. dev.

Depression is a kind of disease
Depression is a personality trait
Having depression means that the person is weak
Physicians should ask patients about depression
Depression is a normal part of aging
Depression is caused by one’s life events
Treatment

492
471
480
483
483
482

4.21
2.62
1.51
4.39
2.49
3.63

1.076
1.264
.993
1.031
1.265
1.124

Depression needs to be treated
Depression improves without treatment
Treatment for depression is embarrassing
Taking medication will make me feel sick
I can control depression by myself
Medication for depression would not help me
Circumstances influencing treatment

500
479
459
457
458
462

4.69
2.40
1.82
2.00
2.41
1.83

.786
1.222
1.210
1.168
1.374
1.059

454
451
456
456
459
453
455

2.11
1.69
1.42
1.47
1.50
1.50
3.95

1.294
1.173
.908
.970
1.012
.981
1.383

Depression

I could not afford treatment
I would not be able to travel to the hospital or clinic to receive treatment
My family would not agree to have me treated
Because of my age, I would not want treatment
Because of my life circumstances, I would not want treatment
Because of many other more important medical problems, I would not want treatment
I would discuss treatment with my family
∗

Scales 1–5, where 1 means strongly disagree, 2 means somewhat disagree, 3 means do not know, 4 means somewhat agree, and 5 means strongly agree.

Table 3: Treatment options.
Statements: if I were depressed, I would
Take medication prescribed by my primary physician
Take medication prescribed by my psychiatrist
Go for counseling
Follow my doctor’s recommendations
Use prayer and meditation as a treatment
Take an herb or other supplement
Increase my alcohol intake
∗

N
466
455
462
460
460
447
455

Mean∗
4.35
4.30
4.26
4.48
3.19
2.63
1.28

Std. dev.
1.145
1.134
1.135
.989
1.517
1.414
.773

Scales 1–5, where 1 means strongly disagree, 2 means somewhat disagree, 3 means do not know, 4 means somewhat agree, and 5 means strongly agree.

agreement, however, differed for certain statements. Persons
without depressive symptoms strongly disagreed with the
statements that having depression means that the person is
weak and that treatment is embarrassing, whereas those with
depressive symptoms only disagreed. A striking finding was
in response to the willingness to discuss treatment with family
members. Greater depressive symptoms were associated with
less conviction that a person would discuss treatment with
family. If physicians believe that it is beneficial to have family
members involved in caring for depressed patients, it may
be wise to encourage patients to have a family member
accompany them to office visits and not to rely on patients
to discuss depressive symptoms and treatment compliance
issues through their own initiative.

Those who believed that depression is caused by life
events had greater acceptance of antidepressants for treatment of their mood. Persons who feel that they have little
intrinsic ability to impact their mood or environment are
defined as having low internal locus of control and, conversely, a high external locus of control. Previous research
has demonstrated an independent link between high external
locus of control and depression. Our observation may reflect
a desire among those with low internal locus of control
to seek out treatment that depends upon as little internal
change as possible [27]. Persons believing that they can
control depression on their own have reduced acceptance
of counseling and a greater tendency to rely on herbal
supplements. Herbal supplements can be purchased without
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Table 4: Depressive symptoms and associations with attitudes about depression and treatment.
PHQ-9 score

N

Mean∗

Std. dev

𝐹†

P value

Depression is a kind of disease

0–4
5–14
15 & up

348
107
26

4.27
4.03
4.50

1.047
1.169
.583

3.052

.048

Having depression means that the person is weak

0–4
5–14
15 & up

338
108
26

1.46
1.54
2.15

.924
1.027
1.488

6.094

.002

Depression is part of normal aging

0–4
5–14
15 & up

340
108
25

2.39
2.79
2.88

1.240
1.261
1.301

5.226

.006

Treatment for depression is embarrassing

0–4
5–14
15 & up

325
103
24

1.73
2.09
2.25

1.118
1.380
1.511

5.013

.007

I could not afford treatment

0–4
5–14
15 & up

324
100
24

1.98
2.47
2.58

1.202
1.473
1.442

7.288

.001

I would not be able to travel to the hospital or clinic to
receive treatment

0–4
5–14
15 & up

321
101
23

1.58
1.95
2.17

1.073
1.374
1.403

6.031

.003

Because of my age, I would not want treatment

0–4
5–14
15 & up

323
102
24

1.40
1.66
1.71

.866
1.130
1.367

3.521

.030

Because of my life circumstances, I would not want
treatment

0–4
5–14
15 & up

325
103
24

1.43
1.75
1.54

.926
1.226
1.103

3.852

.022

Due to many other more important medical problems, I
would not want treatment

0–4
5–14
15 & up

322
102
23

1.43
1.75
1.57

.918
1.103
1.199

4.431

.012

I would discuss treatment with my family

0–4
5–14
15 & up

323
103
24

4.05
3.85
3.17

1.361
1.339
1.579

5.085

.007

I would take medication prescribed by my psychiatrist

0–4
5–14
15 & up

324
102
24

4.31
4.15
4.79

1.142
1.189
.588

3.208

.041

Statement

∗
†

Scales 1–5, where 1 means strongly disagree, 2 means somewhat disagree, 3 means do not know, 4 means somewhat agree, and 5 means strongly agree.
ANOVA.

prescriptions or need to interact with a physician, enhancing
the person’s ability to self-manage their depression.
Perceptions regarding depression from older adults who
are not depressed are also important because of their risk of
developing depression later in life related to cardiovascular
and cerebrovascular disease or other chronic diseases. This
group may also have spouses suffering from depression, and
their attitudes may impact the spouses’ treatment. Caregivers’
beliefs about the root of patient’s depression can strongly
influence medication adherence [28]. In a study examining
adherence to lithium therapy for affective disorders, marriage
was correlated with better adherence over a one-year period
[29]. Marital status had a strong relationship with adherence

to citalopram treatment in adults aged 60 years and older
being seen in a primary care setting [30]. Additionally, those
with poor marital support were more likely to have recurrent
depressive symptoms and fail to comply with treatment one
year after optimum medical therapy [31].
A striking correlate was found regarding the willingness
to discuss treatment with family members. Greater depressive symptoms were associated with less conviction that a
person would discuss treatment with family; however, there
was a strong and consistent correlation with discussion of
depression with family and willingness to accept all treatment
options after accounting for all other variables. Paradoxically,
those most in need of pursing treatment options for their
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Table 5: Multiple linear regression analyses on the treatment options.

Predictors
Meds from primary physician (𝑅2 = 0.16)
(i) History of depression
(ii) Depression needs to be treated
(iii) Depression is caused by one’s life events
(iv) Discuss treatment with family
(v) Depression improves without treatment
(vi) Medications for depression would not help
Meds from psychiatrist (𝑅2 = 0.24)
(i) Higher education
(ii) Depression needs to be treated
(iii) Depression is caused by one’s life events
(iv) Discuss treatment with family
(v) Depression is a personality trait
(vi) Medications for depression would not help
Counseling (𝑅2 = 0.23)
(i) Higher education
(ii) Family does not agree with treatment
(iii) Discuss treatment with family
(iv) Treatment for depression is embarrassing
(v) I can control depression by myself
(vi) Medications for depression would not help
Follow MD’s recommendations (𝑅2 = 0.18)
(i) Higher education
(ii) Discuss treatment with family
(iii) Meds for depression would not help
Prayer and meditation (𝑅2 = 0.29)
(i) Religious belief
(ii) Discuss treatment with family
(iii) Pay health expenses with my earnings
Use herbs or supplements (𝑅2 = 0.10)
(i) Can control depression by myself
(ii) Discuss treatment with family
(iii) Older age
(iv) Higher education
Increase alcohol intake (𝑅2 = 0.14)
(i) Due to life circumstances, I do not want treatment
(ii) Medications for depression would not help
(iii) Discuss treatment with family
(iv) Pay health expenses from my earnings
(v) Religious belief

mood may be the very people least willing to discuss
treatment with their loved ones, leading to poorer outcomes
and undue suffering. This finding is consistent with the use
of psychoeducational workshops for depressed patients and
their families to promote continuation treatment for the
depressed patients [32]. The willingness to discuss treatment
options with family is a condition associated with enhanced
acceptance of medication use, counseling, and following
the doctor’s recommendations. Encouraging patients to have
a family member accompany them to office visits is one

Regression coefficient

t value

P value

.34
.22
.11
.18
−.11
−.13

2.64
2.61
2.08
4.18
−2.26
−2.17

.0088
.0093
.0381
<.0001
.0247
.0310

.22
.22
.12
.19
−.09
−.27

2.25
2.65
2.36
4.63
−2.05
−4.68

.0249
.0084
.0188
<.0001
.0413
<.0001

.26
.16
.21
−.17
−.13
−.17

2.83
2.44
5.45
−3.60
−2.91
−2.94

.0049
.0152
<.0001
.0004
.0039
.0035

.26
.20
−.22

3.08
5.73
−4.59

.0023
<.0001
<.0001

.76
.18
−.37

11.38
3.80
−2.63

<.0001
.0002
.0088

.19
.14
−.03
−.37

3.46
2.73
−3.48
−3.01

.0006
.0066
.0006
.0028

.11
.09
−.10
−.21
−.14

2.45
2.12
−3.41
−2.62
−3.43

.0149
.0347
.0007
.0092
.0007

approach to enhance family communications regarding the
importance of symptom monitoring and treatment compliance.
Our sample was insured, lived in an area with accessible
mental health resources, and did not report cost as a barrier
to depression treatment. The most common reason for not
seeking mental health treatment in a sample of 6,510 adults
was concern about costs [33]. Significant proportions (19%
to 38%) of elderly subjects with depressive symptoms report
cost-related nonadherence to medications [34]. Differing
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healthcare plans have been linked to poor mental health
followup [35] and have been shown to impact access to
antidepressant medication management and other treatment
options [36]. Counseling services are highly variable among
private and state-run health insurances and dependent on
local access and availability of qualified mental health professionals, which may also explain some of the variation in
our results locally and on a national level. Further research
is needed to assess the impact of insurance coverage on the
acceptance of treatments for depression.
Several potential clinical implications arise from this
exploratory study. Screening for depression in primary care
settings is acceptable to older patients. Attitudes of patients
and their circumstances may help predict the acceptability of
and compliance with depression treatments. Attitudes should
be queried after making the diagnosis and before prescribing
treatments. This is similar to the recommendation made
following the study of younger depressed primary care
patients in the United Kingdom [21]. Family involvement in
treatment is an enhancing factor in treatment acceptability.
Offering to discuss depression and treatment options with
both patient and family may help improve compliance and
treatment outcomes.
There are several limitations to the study, including
generalizability and power to detect significant findings in
the smaller depressed sample. The study sample was mainly
drawn from an academic primary care setting and may not
represent the general older, ambulatory population. Although
50 percent of the sample had a college education and less
than one percent had no insurance, characteristics such as
number and kinds of chronic diseases, general health ratings,
and other demographic variables were similar to the general
older population.
To overcome these limitations, a similar study needs
to be conducted with a larger sample size, preferably in
a primary care research network. If attitudinal factors are
related to treatment acceptability, a screening of attitudes
towards depression should be used in an intervention trial.
Physicians do inquire about the acceptability of treatments
before prescribing, but better understanding of the patients’
and families’ beliefs may help determine the extent of education needed for any individual patient. If a strong relationship
between family involvement and treatment acceptance is
confirmed, a comparison trial between usual care and a
family intervention trial would be of value, with the outcome
variables of remission of depression and compliance with
continuation treatment.

5. Conclusions
It is important to understand the patients’ perceptions
regarding depression, as well as other enhancers or barriers
to effective treatment. Patients believe that depression is a
disease that requires treatment and that physicians should
ask their patients about depressive symptoms. The willingness
to discuss depression with family appears to be associated
with greater acceptance of depression treatments. Physicians’
facilitation of these family discussions may be an effective
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approach to increase treatment compliance and improve
depression outcomes.
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